- Home
- TTD vs SNN Comparison
TTD vs SNN Comparison
Compare TTD & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TTD | SNN |
|---|---|---|
| Founded | 2009 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Computer Software: Programming Data Processing | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 13.2B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | TTD | SNN |
|---|---|---|
| Price | $17.95 | $31.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 34 | 2 |
| Target Price | ★ $46.22 | $36.25 |
| AVG Volume (30 Days) | ★ 12.8M | 1.6M |
| Earning Date | 05-07-2026 | 03-16-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | ★ 15.38 | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $2,896,284,000.00 | N/A |
| Revenue This Year | $13.94 | $8.58 |
| Revenue Next Year | $12.61 | $5.60 |
| P/E Ratio | $216.13 | ★ $64.97 |
| Revenue Growth | ★ 18.47 | N/A |
| 52 Week Low | $16.70 | $28.56 |
| 52 Week High | $91.45 | $38.79 |
Technical Indicators
Market Signals| Indicator | TTD | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 46.17 | 55.29 |
| Support Level | $16.98 | $29.14 |
| Resistance Level | $20.54 | $31.18 |
| Average True Range (ATR) | 0.83 | 0.53 |
| MACD | -0.09 | 0.03 |
| Stochastic Oscillator | 41.07 | 75.13 |
Price Performance
Historical ComparisonAbout TTD The Trade Desk Inc.
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. The firm's platform is referred to as a DSP in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising, sometimes referred to as a "take rate".
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.